How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

Chatzidionysiou, Katerina; Delcoigne, Bénédicte; Frisell, Thomas; Hetland, Merete L; Glintborg, Bente; dreyer, lene; Cordtz, René; Zobbe, Kristian; Nordström, Dan; Trokovic, Nina; Aaltonen, Kalle; Provan, Sella Aarrestad; Gröndal, Gerður; Gudbjornsson, Bjorn; Askling, Johan

Opin vísindi
→
Háskóli Íslands
→
Greinar- HÍ
→
Skoða verk

dc.contributor	Háskóli Íslands
dc.contributor	University of Iceland
dc.contributor.author	Chatzidionysiou, Katerina
dc.contributor.author	Delcoigne, Bénédicte
dc.contributor.author	Frisell, Thomas
dc.contributor.author	Hetland, Merete L
dc.contributor.author	Glintborg, Bente
dc.contributor.author	dreyer, lene
dc.contributor.author	Cordtz, René
dc.contributor.author	Zobbe, Kristian
dc.contributor.author	Nordström, Dan
dc.contributor.author	Trokovic, Nina
dc.contributor.author	orcid.org/0000-0002-5650-203X Aaltonen, Kalle
dc.contributor.author	Provan, Sella Aarrestad
dc.contributor.author	Gröndal, Gerður
dc.contributor.author	orcid.org/0000-0003-4631-6505 Gudbjornsson, Bjorn
dc.contributor.author	Askling, Johan
dc.date.accessioned	2020-11-13T14:15:39Z
dc.date.available	2020-11-13T14:15:39Z
dc.date.issued	2020-09-08
dc.identifier.citation	Chatzidionysiou K, Delcoigne B, Frisell T, et alHow do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registersRMD Open 2020;6:e001363. doi: 10.1136/rmdopen-2020-001363
dc.identifier.issn	2056-5933
dc.identifier.uri	https://hdl.handle.net/20.500.11815/2202
dc.description	Publisher's version (útgefin grein)
dc.description.abstract	[No abstract available]
dc.description.sponsorship	This study was partly funded by grants from Nord-Forsk and FOREUM.
dc.format.extent	e001363
dc.language.iso	en
dc.publisher	BMJ
dc.relation.ispartofseries	RMD Open;6(2)
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Arthritis
dc.subject	Biological Therapy
dc.subject	Epidemiology
dc.subject	Rheumatoid
dc.subject	Iktsýki
dc.subject	Líftæknilyf
dc.title	How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers
dc.type	info:eu-repo/semantics/article
dcterms.license	This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
dc.description.version	Peer Reviewed
dc.identifier.journal	RMD Open
dc.identifier.doi	10.1136/rmdopen-2020-001363
dc.relation.url	https://syndication.highwire.org/content/doi/10.1136/rmdopen-2020-001363
dc.contributor.department	Læknadeild (HÍ)
dc.contributor.department	Faculty of Medicine (UI)
dc.contributor.school	Heilbrigðisvísindasvið (HÍ)
dc.contributor.school	School of Health Sciences (UI)